board of directors
BraineHealth AB fully owns different projects such as Diabetio, Lugn&Ro Doktorn, Diagnosio and many more. The board of directors are also managing those projects.
Roger Svenssonfounder and ceo
Roger is the founder and President of BraineHealth AB, the creator of Diabetio and Diagnosio - artificial intelligence applications for healthcare.
Roger is serial entrepreneur and former research leader at Karolinska Institutet, where he successfully spun off several healthcare companies from seed to IPO. The latest one to IPO is CRAD AB, a company providing advanced radiation therapy for cancer treatment worldwide with current market capital of MSEK 1 087.
Roger is also the founder and CEO of Lugn&Ro Sverige AB, a healthcare provider company with 70 employees, where Diabetio and Diagnosio are being improved by its doctors and patients.
Roger has PhD from Stockholm University / Karolinska Institutet, and MBA from Stockholm School of Economics.
Isabella Svensson Rissanenco-founder, vice-ceo, program manager
Isabella is co-founder of BraineHealth AB, where she manages AI solutions and content development.
She is also co-founder and board member of Lugn&Ro Sverige AB, where she co-developed the Lugn&Ro Doktorn, a telemedicine solution with virtual doctor appointments.
Isabella is an experienced project and IT-system manager, and Quality Management System developer for healthcare solutions within diabetes, asthma, and hypertoni.
She is responsible for implementation of multiple public digital healthcare services, 1177 Vårdguiden, in Stockholm County.
She holds studies in science theory, culture, and media from Stockholm University.